Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 125 of 437 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/20/19
End: 05/18/20
Due: 05/18/21
Phase: N/A
Priority: Normal
Start: 02/19/20
End: 03/02/22
Due: 03/02/23
Phase: N/A
Priority: Normal
Start: 05/05/13
End: 10/14/19
Due: 10/14/20
Phase: N/A
Priority: Normal
Start: 06/28/18
End: 09/12/19
Due: 09/12/20
Phase: N/A
Priority: Normal
Start: 03/31/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/10
End: 12/31/13
Due: 12/31/14
Phase: N/A
Priority: Normal
Start: 11/03/14
End: 08/05/21
Due: 08/05/22
Phase: N/A
Priority: Normal
Start: 09/16/19
End: 05/08/21
Due: 05/08/22
Phase: N/A
Priority: Normal
Start: 11/04/21
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 12/17/18
End: 08/11/20
Due: 08/11/21
Phase: N/A
Priority: Normal
Start: 03/04/13
End: 12/19/18
Due: 12/19/19
Phase: N/A
Priority: Normal
Start: 02/28/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 01/24/19
End: 01/31/28
Due: 01/31/29
Phase: N/A
Priority: Normal
Start: 04/10/17
End: 04/09/19
Due: 04/09/20
Phase: N/A
Priority: Normal
Start: 06/27/17
End: 04/24/18
Due: 04/24/19
Phase: N/A
Priority: Normal
Start: 11/15/17
End: 12/15/18
Due: 12/15/19
Phase: N/A
Priority: Normal
Start: 01/16/23
End: 01/16/24
Due: 01/16/25
Phase: N/A
Priority: Normal
Start: 07/05/16
End: 01/13/17
Due: 01/13/18
Phase: N/A
Priority: Normal
Start: 01/12/09
End: 09/30/19
Due: 09/30/20
Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 01/31/14
Due: 01/31/15
Phase: N/A
Priority: Normal
Start: 02/03/20
End: 08/03/28
Due: 08/03/29
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 06/30/17
Due: 06/30/18
Phase: N/A
Priority: Normal
Start: 01/10/18
End: 07/30/21
Due: 07/30/22
Phase: N/A
Priority: Normal
Start: 09/30/03
End: 02/28/06
Due: 02/28/07
Phase: N/A
Priority: Normal
Start: 06/19/23
End: 10/30/24
Due: 10/30/25